We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$391M
AUM Growth
+$24.9M
Cap. Flow
+$6.5M
Cap. Flow %
1.66%
Top 10 Hldgs %
24.49%
Holding
285
New
24
Increased
110
Reduced
87
Closed
16
Avg Time Held Equity + Options
14 quarters
Top 10 Avg Time Held Equity + Options
10.8 quarters
Top 20 Avg Time Held Equity + Options
12.8 quarters
Avg Time Held Equity only
14 quarters
Top 10 Avg Time Held Equity only
10.8 quarters
Top 20 Avg Time Held Equity only
12.8 quarters

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$3.14M
2
META icon
Meta Platforms (Facebook)
META
+$1.99M
3
NVDA icon
NVIDIA
NVDA
+$1.87M
4
AMZN icon
Amazon
AMZN
+$1.54M
5
GILD icon
Gilead Sciences
GILD
+$1.47M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.37%
2 Technology 20.82%
3 Consumer Discretionary 13.26%
4 Financials 10.08%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FTCS icon
201
First Trust Capital Strength ETF
FTCS
$7.54B
$372K 0.1%
+4,100
New +$359K
2024 Q3
0 quarters
SNN icon
202
Smith & Nephew
SNN
$11.7B
$361K 0.09%
11,592
– –
2022 Q3
8 quarters
CRM icon
203
Salesforce
CRM
$196B
$351K 0.09%
1,281
-3,814
-75% -$977K
2016 Q4
31 quarters
BITB icon
204
Bitwise Bitcoin ETF
BITB
$3.08B
$348K 0.09%
+10,050
New +$334K
2024 Q3
0 quarters
AON icon
205
Aon
AON
$58.3B
$343K 0.09%
992
+31
+3% +$10.1K
2024 Q2
1 quarter
KLAC icon
206
KLA
KLAC
$240B
$342K 0.09%
4,420
-39,990
-90% -$3.14M
2016 Q4
31 quarters
FPF icon
207
First Trust Intermediate Duration Preferred & Income Fund
FPF
$958M
$335K 0.09%
17,130
+2,146
+14% +$39.8K
2022 Q2
9 quarters
EEM icon
208
iShares MSCI Emerging Markets ETF
EEM
$30.5B
$334K 0.09%
7,274
-2,200
-23% -$94.9K
2019 Q1
22 quarters
GE icon
209
GE Aerospace
GE
$319B
$332K 0.08%
1,758
-38
-2% -$6.44K
2022 Q2
9 quarters
CRSP icon
210
CRISPR Therapeutics
CRSP
$4.84B
$323K 0.08%
6,881
+125
+2% +$6.34K
2019 Q4
19 quarters
COST icon
211
Costco
COST
$423B
$323K 0.08%
364
+7
+2% +$6.08K
2023 Q2
5 quarters
MOS icon
212
The Mosaic Company
MOS
$6.1B
$320K 0.08%
+11,950
New +$329K
2024 Q3
0 quarters
FDX icon
213
FedEx
FDX
$68.8B
$319K 0.08%
1,160
– –
2020 Q1
18 quarters
AFMD icon
214
DELISTED
Affimed
AFMD
$317K 0.08%
94,361
+10,250
+12% +$45.2K
2021 Q2
13 quarters
GSAT icon
215
Globalstar
GSAT
$10.7B
$317K 0.08%
17,034
– –
2019 Q3
20 quarters
EXPO icon
216
Exponent
EXPO
$3.39B
$312K 0.08%
2,705
– –
2022 Q4
7 quarters
UPST icon
217
Upstart Holdings
UPST
$2.32B
$308K 0.08%
+7,700
New +$256K
2024 Q3
0 quarters
T icon
218
AT&T
T
$157B
$305K 0.08%
13,884
-746
-5% -$14.8K
2020 Q4
15 quarters
FBTC icon
219
Fidelity Wise Origin Bitcoin Fund
FBTC
$15.4B
$305K 0.08%
5,500
– –
2024 Q1
2 quarters
VOO icon
220
Vanguard S&P 500 ETF
VOO
$1.05T
$300K 0.08%
567
-219
-28% -$111K
2021 Q1
14 quarters
VTI icon
221
Vanguard Morningstar Total Stock Market ETF
VTI
$702B
$287K 0.07%
1,011
-543
-35% -$148K
2021 Q1
14 quarters
PZC
222
DELISTED
PIMCO California Municipal Income Fund III
PZC
$282K 0.07%
37,500
+2,500
+7% +$18.3K
2024 Q1
2 quarters
DSGX icon
223
Descartes Systems
DSGX
$7.26B
$279K 0.07%
2,705
– –
2023 Q4
3 quarters
JOBY icon
224
Joby Aviation
JOBY
$4.93B
$276K 0.07%
54,900
-9,700
-15% -$52.8K
2022 Q2
9 quarters
BSV icon
225
Vanguard Short-Term Bond ETF
BSV
$45.4B
$275K 0.07%
3,500
– –
2019 Q1
22 quarters

Similar funds

Intellectus Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Intellectus Partners held 285 positions worth $391M, up 6.8% from $366M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Intellectus Partners's Q3 2024 filing shows 24 new, 110 increased, 87 reduced and 16 closed positions. Its largest new stake was Corcept Therapeutics: 54,859 shares worth $2.54M. The largest sale was KLA, an estimated $3.14M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Intellectus Partners's largest Q3 2024 buy was Corcept Therapeutics: 54,859 shares worth $2.54M.
  • Intellectus Partners added most to Snowflake in Q3 2024, an estimated $1.78M increase.
  • Intellectus Partners's biggest Q3 2024 reduction was KLA, cutting an estimated $3.14M.
  • Intellectus Partners fully exited Biogen in Q3 2024, selling an estimated $1.4M.
  • Intellectus Partners's ten largest holdings make up 24% of its $391M portfolio in Q3 2024.
  • Intellectus Partners opened 24 new positions and closed 16 in Q3 2024.
  • Intellectus Partners's portfolio value rose 6.8% quarter-over-quarter to $391M.

Based on Intellectus Partners's 13F filing for Q3 2024, filed 6 Nov 2024.